53 F
Fort Worth
Tuesday, December 1, 2020
Health Care Pfizer reports encouraging, very early vaccine test results

Pfizer reports encouraging, very early vaccine test results

Other News

Pfizer says COVID-19 vaccine is looking 90% effective

By LAURAN NEERGAARD and LINDA A. JOHNSON AP Medical Writers Pfizer Inc. said Monday that its COVID-19 vaccine may be a remarkable 90% effective, based...

Fauci: Halt of coronavirus trial is “safety valve” at work

By LAURAN NEERGAARD AP Medical Writer The top U.S. infectious disease expert said AstraZeneca’s suspension of final testing of its COVID-19 vaccine candidate shows “one...

Companies testing vaccines pledge safety, high standards

By LINDA A. JOHNSON AP Medical Writer The top executives of nine drugmakers likely to produce the first vaccines against the new coronavirus signed an...

Commentary: Value vs. values – business critics ought to check the numbers

Neal Shields Recently the Business Roundtable made a statement that American businesses needed to pay greater attention to their responsibilities to “stakeholders” and society. The Neeley...

By The Associated Press

The first of four experimental COVID-19 vaccines being tested by Pfizer and its German partner BioNTech showed encouraging results in very early testing of 45 people, the companies said Wednesday.

Study volunteers given either a low or medium dose, in two shots about a month apart, had immune responses in the range expected to be protective, when compared to some COVID-19 survivors, according to the preliminary results.

Side effects were typical for vaccines, mostly pain at the injection site and fever.

The report has been submitted for publication in a scientific journal but not yet reviewed. With its other potential candidates still in the earliest stage of testing, Pfizer aims to open a large-scale study this summer but can’t yet say which shot is best to include.

But researchers didn’t administer a second shot of the highest dose initially tested, sticking with the low and medium doses. The higher-dose shot caused more injection reactions without apparent added benefit.

About 15 different COVID-19 vaccine candidates are in human testing worldwide, with several poised to begin huge, last-stage studies to prove if they really work.

Different companies are pursuing different types of vaccines, boosting the odds that at least one approach might work — although there’s no guarantee. The Pfizer and BioNTech candidates use a piece of the coronavirus genetic code to prime the body to recognize and attack the virus.

Earlier this week, Inovio Pharmaceuticals issued a news release saying its gene-based vaccine candidate showed encouraging results in similar early testing in 40 volunteers.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

close

Oh hi there 👋
It’s nice to meet you.

Sign up to receive awesome content in your inbox.

We don’t spam! Read our privacy policy for more info.

Latest News

Crystal Mason, jailed for illegal voting conviction after casting provisional ballot, seeks to have conviction overturned

A Fort Worth woman jailed for casting a provisional ballot in the 2016 presidential election while on supervised release for a federal conviction is...

Mayor Price announces COVID recovery as cases surge in Texas

Fort Worth Mayor Betsy Price announced that she and her husband, Tom, have both recovered from COVID-19 on Monday, Nov. 30. “I am pleased to...

Q&A with Jaime Cobb/James L. West Center Vice President of Caregiver & Community Education

FWBP: Now that visiting restrictions are changing in long-term care, what do family members need to know? Jaime Cobb: Long-term care is still learning what...

COVID hospitalizations shut down bars in Texas county

By JUAN A. LOZANO Associated PressHOUSTON (AP) — A Central Texas county has closed its bars after area hospitalizations for COVID-19 exceeded a state...

U.S. Supreme Court leery of Trump’s bid to exclude undocumented immigrants from congressional reapportionment

Some Supreme Court justices on Monday seemed skeptical of President Trump’s claim he has the authority to exclude undocumented immigrants from population totals when...